These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21497623)

  • 1. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    Drug Deliv Transl Res; 2011 Dec; 1(6):429-38. PubMed ID: 25786363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
    Lee KW; Nguyen TH; Hanley T; Boyd BJ
    Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
    Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
    Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
    Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
    Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
    Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
    Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines.
    Rizwan SB; Assmus D; Boehnke A; Hanley T; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2011 Sep; 79(1):15-22. PubMed ID: 21237267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.
    Rizwan SB; Hanley T; Boyd BJ; Rades T; Hook S
    J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
    Dong YD; Larson I; Hanley T; Boyd BJ
    Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol.
    Tilley A; Dong YD; Amenitsch H; Rappolt M; Boyd BJ
    Phys Chem Chem Phys; 2011 Feb; 13(8):3026-32. PubMed ID: 21240427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
    Bhatt AB; Barnes TJ; Prestidge CA
    Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.
    Tilley AJ; Drummond CJ; Boyd BJ
    J Colloid Interface Sci; 2013 Feb; 392():288-296. PubMed ID: 23137909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
    Fong WK; Hanley T; Boyd BJ
    J Control Release; 2009 May; 135(3):218-26. PubMed ID: 19331865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats.
    Okawara M; Hashimoto F; Todo H; Sugibayashi K; Tokudome Y
    Int J Pharm; 2014 Sep; 472(1-2):257-61. PubMed ID: 24954725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.